Patients treated with low-dose anthracyclines often show late onset cardiotoxicity. Recent studies suggest that this form of cardiotoxicity is the result of a progenitor cell disease. In this study we demonstrate that Cord Blood Endothelial Progenitor Cells (EPCs) exposed to low. sub-apoptotic doses of doxorubicin show a senescence phenotype characterized by increased SA-b-gal activity. https://macorners.shop/product-category/flag/